Predictive Oncology (POAI) Competitors $0.87 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$0.86 -0.01 (-0.57%) As of 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock POAI vs. COCH, VVOS, CLGN, FEMY, DRIO, PETV, RVP, IRIX, ALUR, and NXGLShould you be buying Predictive Oncology stock or one of its competitors? The main competitors of Predictive Oncology include Envoy Medical (COCH), Vivos Therapeutics (VVOS), CollPlant Biotechnologies (CLGN), Femasys (FEMY), DarioHealth (DRIO), PetVivo (PETV), Retractable Technologies (RVP), IRIDEX (IRIX), Allurion Technologies (ALUR), and NexGel (NXGL). These companies are all part of the "medical equipment" industry. Predictive Oncology vs. Its Competitors Envoy Medical Vivos Therapeutics CollPlant Biotechnologies Femasys DarioHealth PetVivo Retractable Technologies IRIDEX Allurion Technologies NexGel Predictive Oncology (NASDAQ:POAI) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings. Do insiders & institutionals have more ownership in POAI or COCH? 9.0% of Predictive Oncology shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 3.4% of Predictive Oncology shares are held by company insiders. Comparatively, 58.9% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media favor POAI or COCH? In the previous week, Predictive Oncology had 3 more articles in the media than Envoy Medical. MarketBeat recorded 5 mentions for Predictive Oncology and 2 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 0.94 beat Predictive Oncology's score of -0.34 indicating that Envoy Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Predictive Oncology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, POAI or COCH? Predictive Oncology has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPredictive Oncology$1.62M5.49-$12.66M-$3.05-0.29Envoy Medical$220K142.81-$20.80M-$1.43-1.02 Is POAI or COCH more profitable? Predictive Oncology has a net margin of -672.89% compared to Envoy Medical's net margin of -10,961.26%. Envoy Medical's return on equity of 0.00% beat Predictive Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Predictive Oncology-672.89% -1,555.67% -137.07% Envoy Medical -10,961.26%N/A -236.14% Which has more risk & volatility, POAI or COCH? Predictive Oncology has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.21, suggesting that its share price is 121% more volatile than the S&P 500. Do analysts prefer POAI or COCH? Predictive Oncology presently has a consensus price target of $3.00, indicating a potential upside of 244.83%. Envoy Medical has a consensus price target of $9.25, indicating a potential upside of 533.56%. Given Envoy Medical's stronger consensus rating and higher probable upside, analysts plainly believe Envoy Medical is more favorable than Predictive Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Predictive Oncology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryEnvoy Medical beats Predictive Oncology on 9 of the 16 factors compared between the two stocks. Get Predictive Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for POAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding POAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POAI vs. The Competition Export to ExcelMetricPredictive OncologyMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.89M$2.02B$5.62B$9.84BDividend YieldN/AN/A4.61%4.07%P/E Ratio-0.2932.0030.2925.74Price / Sales5.499.82463.41115.83Price / CashN/A51.7138.2159.48Price / Book-29.005.778.826.15Net Income-$12.66M-$62.35M$3.25B$265.06M7 Day Performance15.60%2.37%4.05%2.80%1 Month Performance8.75%-0.05%4.32%1.68%1 Year Performance-1.09%25.62%36.25%29.59% Predictive Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POAIPredictive Oncology1.5904 of 5 stars$0.87flat$3.00+244.8%-12.2%$8.89M$1.62M-0.2930News CoverageEarnings ReportGap UpCOCHEnvoy Medical3.4578 of 5 stars$1.43-1.0%$9.25+546.9%-42.6%$30.82M$220K-1.0034VVOSVivos Therapeutics0.8767 of 5 stars$4.76-8.1%$4.82+1.2%+100.4%$30.51M$15.03M-2.75160News CoverageGap DownCLGNCollPlant Biotechnologies2.8907 of 5 stars$2.25-1.7%$11.50+411.1%-39.3%$29.13M$510K-1.8470News CoverageUpcoming EarningsFEMYFemasys2.953 of 5 stars$0.81-1.4%$8.67+972.2%-29.7%$26.66M$1.70M-0.8930News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionGap UpDRIODarioHealth1.4778 of 5 stars$0.55+0.0%$2.00+263.6%-50.8%$25.03M$27.04M-0.98200News CoverageGap DownPETVPetVivoN/A$0.80-1.0%N/A+68.3%$22.00M$1.05M-1.7820News CoverageGap DownRVPRetractable Technologies1.9945 of 5 stars$0.73-1.7%N/A-22.8%$21.86M$33.75M-1.35240News CoverageShort Interest ↑Gap UpIRIXIRIDEX1.265 of 5 stars$1.32+3.1%N/A-40.1%$21.49M$48.67M-3.07120News CoveragePositive NewsEarnings ReportALURAllurion Technologies2.6122 of 5 stars$2.85+2.9%$22.83+701.2%-86.8%$20.62M$32.11M-0.23501News CoverageShort Interest ↓Analyst RevisionNXGLNexGel1.3932 of 5 stars$2.60+1.2%N/A-13.7%$19.67M$8.69M-5.7810News CoverageEarnings ReportUpcoming EarningsShort Interest ↓ Related Companies and Tools Related Companies Envoy Medical Competitors Vivos Therapeutics Competitors CollPlant Biotechnologies Competitors Femasys Competitors DarioHealth Competitors PetVivo Competitors Retractable Technologies Competitors IRIDEX Competitors Allurion Technologies Competitors NexGel Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:POAI) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access